Global Ineffective Esophageal Motility Treatment Market Report By Product (Devices (Reflux Management Systems , Endoscopic Pain Modulators,Endostaplers,Radiofrequency (RF) Ablation Devices,Myotomy Devices),Drugs (H2 Receptor Antagonists,Antacids,Proton Pump Inhibitors,Dopamine Antagonists,Prokinetic Agents,Calcium Channel Blockers), By Indication (Dysphagia,GERD,Burning Chest Pain,Achalasia), By End User (Institutional Sales,Hospitals,Ambulatory Surgical Centers,Retail Sales,Retail Pharmacies,Drug Stores,Mail Order Pharmacies) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Ineffective Esophageal Motility Treatment Market Report
Brand: Value Market Research
SKU: Healthcare
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11213837

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Ineffective Esophageal Motility Treatment Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022-2028.

Ineffective esophageal motility (IEM) is a medical condition in which the patient suffers from dysphagia (swallowing difficulty) and reflux. The causes of (IEM) include old age, diabetes, acid reflux, scleroderma, Parkinson's disease, achalasia, polymyositis amyotrophic lateral sclerosis. The IEM symptoms include difficulty in eating, heartburn, cough, excessive throat mucus, the sensation of a lump in the throat, and regurgitation. The proper diagnosis and treatment of IEM are essential as traditional anti-reflux medicines do not improve the condition. IEM treatment plan includes relaxation of lower esophageal sphincter (LES) muscles by proper medication or relieving the physiologic blockage at LES level by the surgical or endoscopic procedure. The other treatment option includes pharmacologic therapy.

Market Dyanamics

The global IEM treatment market is growing fast owing to the increasing geriatric population and increased prevalence of IEM & gastroesophageal reflux. Moreover, factors such as increasing R & D in IEM and other related medical conditions and advancement in treatment procedures such as radiofrequency stimulation of LES muscles are boosting the market. Growing adoption for minimally invasive treatments and drug-based treatments is further propelling the global market.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each segment in the global market of ineffective esophageal motility treatment.

Market Segmentation

This section of the ineffective esophageal motility treatment market report provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.

By Product

Devices (Reflux Management Systems , Endoscopic Pain Modulators,Endostaplers,Radiofrequency (RF) Ablation Devices,Myotomy Devices)
Drugs (H2 Receptor Antagonists,Antacids,Proton Pump Inhibitors,Dopamine Antagonists,Prokinetic Agents,Calcium Channel Blockers)

By Indication

Dysphagia
GERD
Burning Chest Pain
Achalasia

By End User

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for ineffective esophageal motility treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global Ineffective Esophageal Motility Treatment Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the ineffective esophageal motility treatment market include Johnson & Johnson, Mylan Pharmaceutical, MediGus Ltd., Torax Medical, Medtronic plc., AstraZeneca plc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc., Bayer AGS. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot

3 . INEFFECTIVE ESOPHAGEAL MOTILITY TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Product
           3.7.2 By Indication
         3.7.3 By End User
           3.7.4 By Region

4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5. IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL INEFFECTIVE ESOPHAGEAL MOTILITY TREATMENT MARKET ANALYSIS BY PRODUCT
       6.1 Overview by Product
       6.2 Historical and Forecast Data
       6.3 Analysis by Product
       6.4 Devices Market by Regions
       6.6 Drugs Market by Regions

7 . GLOBAL INEFFECTIVE ESOPHAGEAL MOTILITY TREATMENT MARKET ANALYSIS BY INDICATION
       7.1 Overview by Indication
       7.2 Historical and Forecast Data
       7.3 Analysis by Indication
       7.4 Dysphagia Market by Regions
       7.5 GERD Market by Regions
       7.6 Burning Chest Pain Market by Regions
       7.7 Achalasia Market by Regions

8 . GLOBAL INEFFECTIVE ESOPHAGEAL MOTILITY TREATMENT MARKET ANALYSIS BY END USER
       8.1 Overview by End User
       8.2 Historical and Forecast Data
       8.3 Analysis by End User
       8.4 Institutional Sales Market by Regions
       8.5 Hospitals Market by Regions
       8.6 Ambulatory Surgical Centers Market by Regions
       8.7 Retail Sales Market by Regions
       8.8 Retail Pharmacies Market by Regions
       8.9 Drug Stores Market by Regions
       8.10. Mail Order Pharmacies Market by Regions

9 . GLOBAL INEFFECTIVE ESOPHAGEAL MOTILITY TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview, Historic and Forecast Data
           9.3.2. North America By Segment
           9.3.3. North America By Country
           9.3.4. United State
           9.3.5. Canada
           9.3.6. Mexico
       9.4. Europe
           9.4.1. Overview, Historic and Forecast Data
           9.4.2. Europe by Segment
           9.4.3. Europe by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7. Italy
           9.4.8. Russia
           9.4.9. Rest Of Europe
       9.5. Asia Pacific
           9.5.1. Overview, Historic and Forecast Data
           9.5.2. Asia Pacific by Segment
           9.5.3. Asia Pacific by Country
           9.5.4. China
           9.5.5. India
           9.5.6. Japan
           9.5.7. South Korea
           9.5.8. Australia
           9.5.9. Rest Of Asia Pacific
       9.6. Latin America
           9.6.1. Overview, Historic and Forecast Data
           9.6.2. Latin America by Segment
          9.6.3. Latin America by Country
           9.6.4. Brazil
           9.6.5. Argentina
           9.6.6. Peru
           9.6.7. Chile
           9.6.8. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview, Historic and Forecast Data
           9.7.2. Middle East & Africa by Segment
           9.7.3. Middle East & Africa by Country
           9.7.4. Saudi Arabia
           9.7.5. UAE
           9.7.6. Israel
           9.7.7. South Africa
           9.7.8. Rest Of Middle East And Africa

10 . COMPETITIVE LANDSCAPE OF THE INEFFECTIVE ESOPHAGEAL MOTILITY TREATMENT COMPANIES
       10.1. Ineffective Esophageal Motility Treatment Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments

11 . COMPANY PROFILES OF INEFFECTIVE ESOPHAGEAL MOTILITY TREATMENT INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Johnson & Johnson
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Mylan Pharmaceutical
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. MediGus Ltd.
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Torax Medical
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Medtronic plc
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. AstraZeneca plc
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Teva Pharmaceutical Industries Ltd.
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Takeda Pharmaceutical Company Limited
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. GlaxoSmithKline plc
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments
       11.12. Bayer AGS
           11.12.1. Company Overview
           11.12.2. Financials
           11.12.3. Products
           11.12.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Ineffective Esophageal Motility Treatment Report
Market Research Process
Market Research Methodology
Global Ineffective Esophageal Motility Treatment Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Product
Market Attractiveness Analysis by Indication
Market Attractiveness Analysis by End User
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Product (USD MN)
Devices Market by Geography (USD MN)
Drugs Market by Geography (USD MN)
Global Market Analysis by Indication (USD MN)
Dysphagia Market by Geography (USD MN)
GERD Market by Geography (USD MN)
Burning Chest Pain Market by Geography (USD MN)
Achalasia Market by Geography (USD MN)
Global Market Analysis by End User (USD MN)
Institutional Sales Market by Geography (USD MN)
Hospitals Market by Geography (USD MN)
Ambulatory Surgical Centers Market by Geography (USD MN)
Retail Sales Market by Geography (USD MN)
Retail Pharmacies Market by Geography (USD MN)
Drug Stores Market by Geography (USD MN)
Mail Order Pharmacies Market by Geography (USD MN)
Global Market by Revenue
North America Market by Revenue
Europe Market by Revenue
Asia Pacific Market by Revenue
Latin America Market by Revenue
Middle East & Africa Market by Revenue
Recent Development in Industry
Company Market Share Analysis

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "